Parkwalk Advisors

Parkwalk Advisors Ltd is a venture capital firm based in London, specializing in investments in growth capital and spin-outs from UK universities and research-intensive institutions. Founded in 2009, the firm targets early to growth-stage companies across various sectors, including healthcare, technology, cleantech, and advanced materials, among others. Parkwalk focuses on businesses that possess intellectual property and the freedom to operate, often originating from academic institutions. The firm typically invests between £250,000 and £10 million and is stage agnostic, participating in funding rounds from seed to Series C and beyond. Parkwalk seeks to capitalize on the attractive tax relief offered by the UK government to stimulate investment in innovative companies, thereby promoting economic growth. The firm utilizes extensive networks in academia and venture capital to identify high-quality investment opportunities. In 2017, Parkwalk became a subsidiary of IP Group Plc, enhancing its capacity to commercialize intellectual property.

Neil Cameron

Investment Director

Enrico D'Angelo

Finance Director

Cassie Doherty

Investment Director

Alastair Kilgour

Founder

Kathy Samii

COO

Emilie Syed

Investment Manager

Alun Williams

Investment Director

Moray Wright

Partner, Co-Founder

Karolina Zapadka

Senior Investment Manager

Past deals in Wearables

Ceryx Medical

Seed Round in 2022
Ceryx Medical Limited specializes in the development and manufacturing of bio-electronic devices designed to address various autonomic and rhythmical bodily processes, including peristalsis, heart rate, and walking. Founded in 2016 and based in Bath, United Kingdom, the company leverages unique, patent-protected chip technology to create artificial Central Pattern Generators (CPGs). These CPGs aim to mimic natural nerve centers in the body, offering potential therapeutic solutions for individuals whose physiological functions have been compromised due to disease or injury. Ceryx Medical's innovative approach seeks to restore normal bodily performance, particularly in the context of conditions such as heart failure.

GripAble

Series A in 2022
Gripable is develops simple digital therapy tools, combining them with mobile games, motivating physically impaired patients. GripAble began during our research with stroke patients struggling to use their hands for simple activities. Everyday tasks - getting dressed in the morning, holding a glass of water - are a huge frustration for them. This is the reality for over 500 million people around the world suffering with impaired arm mobility. These patients need, and want, more therapy. GripAble's first product is a highly sensitive, portable hand-grip that connects wirelessly with a mobile-based app, allowing patients to play our fun therapy games. It is designed for low-cost, easy-access assessment and therapy of hand and arm disability, providing increased engagement and allowing for self-training in hospitals and at home.

SERG Technologies

Seed Round in 2022
SERG Technologies is focused on transforming the interaction between individuals and technology through the development of advanced wearables and a digital health platform. Their innovative sensors capture subtle, subconscious movements to generate control signals for various devices, allowing for efficient operation of smart technology. Additionally, SERG is dedicated to improving the lives of individuals with Parkinson's and other neurodegenerative movement disorders by providing tools for continuous and personalized symptom assessment. This platform delivers actionable insights that aid in optimizing medication and treatment plans, empowering patients to better manage their conditions and enhance their mobility and independence. Through these initiatives, SERG Technologies aims to make gesture control and health monitoring more accessible and user-friendly for all.

OW Smell Digital

Seed Round in 2022
Modern graphical user interface design uses a set of reusable components to create intuitive interactions. Here at OWidgets we aim to create a similar set of components for olfactory interactions, fully exploiting the properties of the sense of smell - Olfactory Widgets.

Charco Neurotech

Seed Round in 2021
Developer of health care devices designed to help people with Parkinson's improve their quality of life. The company develops a non-invasive wearable device that modulates sensory dysfunction, helping people with Parkinson's disease to improve their movement speed while living a normal life.

GripAble

Seed Round in 2021
Gripable is develops simple digital therapy tools, combining them with mobile games, motivating physically impaired patients. GripAble began during our research with stroke patients struggling to use their hands for simple activities. Everyday tasks - getting dressed in the morning, holding a glass of water - are a huge frustration for them. This is the reality for over 500 million people around the world suffering with impaired arm mobility. These patients need, and want, more therapy. GripAble's first product is a highly sensitive, portable hand-grip that connects wirelessly with a mobile-based app, allowing patients to play our fun therapy games. It is designed for low-cost, easy-access assessment and therapy of hand and arm disability, providing increased engagement and allowing for self-training in hospitals and at home.

Entia

Series A in 2021
Entia Ltd is a medical technology company based in London, United Kingdom, that focuses on enhancing access to blood tests through innovative healthcare devices. Founded in 2014, Entia offers two primary products: Aptus, a device for testing haemoglobin and haematocrit levels, and Affinity, designed for cancer patients to monitor their blood counts from home. These devices facilitate health screening, blood donor screening, maternal and child health, nutrition, and sports applications, while also enabling cancer patients to manage their health more effectively, reducing the risk of infection and minimizing hospital visits. The company employs a multidisciplinary team that encompasses design, engineering, quality assurance, and business development, all aimed at improving patients' quality of life by allowing them to conduct essential health monitoring from the comfort of their homes.

GripAble

Seed Round in 2021
Gripable is develops simple digital therapy tools, combining them with mobile games, motivating physically impaired patients. GripAble began during our research with stroke patients struggling to use their hands for simple activities. Everyday tasks - getting dressed in the morning, holding a glass of water - are a huge frustration for them. This is the reality for over 500 million people around the world suffering with impaired arm mobility. These patients need, and want, more therapy. GripAble's first product is a highly sensitive, portable hand-grip that connects wirelessly with a mobile-based app, allowing patients to play our fun therapy games. It is designed for low-cost, easy-access assessment and therapy of hand and arm disability, providing increased engagement and allowing for self-training in hospitals and at home.

Ceryx Medical

Seed Round in 2020
Ceryx Medical Limited specializes in the development and manufacturing of bio-electronic devices designed to address various autonomic and rhythmical bodily processes, including peristalsis, heart rate, and walking. Founded in 2016 and based in Bath, United Kingdom, the company leverages unique, patent-protected chip technology to create artificial Central Pattern Generators (CPGs). These CPGs aim to mimic natural nerve centers in the body, offering potential therapeutic solutions for individuals whose physiological functions have been compromised due to disease or injury. Ceryx Medical's innovative approach seeks to restore normal bodily performance, particularly in the context of conditions such as heart failure.

GaitQ

Seed Round in 2020
GaitQ is a developer of a medical device used to help people living with Parkinson's disease to overcome freezing of gait. Its small, portable device uses clinically proven sensory cues that enable patients to re-establish the connection between the brain and the body helps the patients to walk smoothly again.

Ceryx Medical

Seed Round in 2020
Ceryx Medical Limited specializes in the development and manufacturing of bio-electronic devices designed to address various autonomic and rhythmical bodily processes, including peristalsis, heart rate, and walking. Founded in 2016 and based in Bath, United Kingdom, the company leverages unique, patent-protected chip technology to create artificial Central Pattern Generators (CPGs). These CPGs aim to mimic natural nerve centers in the body, offering potential therapeutic solutions for individuals whose physiological functions have been compromised due to disease or injury. Ceryx Medical's innovative approach seeks to restore normal bodily performance, particularly in the context of conditions such as heart failure.

Flusso

Series A in 2020
Flusso Ltd, established in 2016 and located in Cambridge, United Kingdom, specializes in the development of advanced flow sensors. Currently operating in stealth mode, the company is focused on creating the world's smallest flow sensor, utilizing fabless semiconductor technology to blend hardware, software, and mechanical components. Flusso's innovative sensors are designed to be significantly smaller and more cost-effective, while also enhancing functionality without sacrificing performance. This approach allows the flow sensing industry to benefit from lower power consumption, ultra-fast response times, on-chip multisensory integration, embedded intelligence, and the capability for high-volume production at reduced unit costs.

Sorex Sensors

Series A in 2020
Sorex Sensors Limited specializes in the design and manufacturing of film bulk acoustic resonator (FBAR) technology-based micro-electro-mechanical system (MEMS) mass sensors for both industrial and consumer applications. The sensors are constructed on silicon wafers and utilize a thin film of piezoelectric material, enabling them to measure mass by detecting changes in resonant frequency when mass is applied to their surface. These sensors are characterized by their dual-mode capability, allowing simultaneous measurement of mass and temperature, with mass sensitivity reaching the femtogram range and temperature resolution down to 0.2 °C. Their compact size and low power consumption make them suitable for various applications, including thin film metrology, particulate monitoring, and gas detection. Sorex Sensors was incorporated in 2017 and is headquartered in the United Kingdom.

PervasID

Series A in 2020
PervasID Limited, founded in 2011 and based in Cambridge, United Kingdom, specializes in the development of wide area passive RFID systems. The company emerged from research conducted at the University of Cambridge and focuses on providing location capabilities based on the EPC Class1 Gen2 standard. PervasID's technology employs fixed ultra-high frequency RFID to accurately detect passive tags over long distances, facilitating enhanced visibility into goods, assets, and people. Its innovative systems are designed to serve various industries, including retail, healthcare, supply chain and logistics, and aviation. The technology has been successfully deployed in multiple field trials, demonstrating its reliability and effectiveness in streamlining processes across diverse markets.

Entia

Series A in 2019
Entia Ltd is a medical technology company based in London, United Kingdom, that focuses on enhancing access to blood tests through innovative healthcare devices. Founded in 2014, Entia offers two primary products: Aptus, a device for testing haemoglobin and haematocrit levels, and Affinity, designed for cancer patients to monitor their blood counts from home. These devices facilitate health screening, blood donor screening, maternal and child health, nutrition, and sports applications, while also enabling cancer patients to manage their health more effectively, reducing the risk of infection and minimizing hospital visits. The company employs a multidisciplinary team that encompasses design, engineering, quality assurance, and business development, all aimed at improving patients' quality of life by allowing them to conduct essential health monitoring from the comfort of their homes.

Inductosense

Series A in 2019
Inductosense Ltd specializes in the manufacture of wireless, battery-free sensors designed for the detection of cracks, corrosion, and defects in various structures and products. Founded in 2015 and based in Bristol, United Kingdom, the company offers innovative solutions such as the WAND Evaluation System, which includes a handheld measurement probe and multiple sensors for measuring structural thickness. Their technology enables sensors to be permanently affixed to surfaces or embedded within materials, allowing for inspections beneath coatings, insulation, or repairs. Additionally, Inductosense provides TRND systems for monitoring internal corrosion and erosion in pipework and vessels. The sensors operate passively, receiving power and transmitting data through non-contact inductive coupling, facilitating fast and repeatable inspections while enabling clients to trend data over time.

Flusso

Venture Round in 2019
Flusso Ltd, established in 2016 and located in Cambridge, United Kingdom, specializes in the development of advanced flow sensors. Currently operating in stealth mode, the company is focused on creating the world's smallest flow sensor, utilizing fabless semiconductor technology to blend hardware, software, and mechanical components. Flusso's innovative sensors are designed to be significantly smaller and more cost-effective, while also enhancing functionality without sacrificing performance. This approach allows the flow sensing industry to benefit from lower power consumption, ultra-fast response times, on-chip multisensory integration, embedded intelligence, and the capability for high-volume production at reduced unit costs.

PervasID

Series A in 2018
PervasID Limited, founded in 2011 and based in Cambridge, United Kingdom, specializes in the development of wide area passive RFID systems. The company emerged from research conducted at the University of Cambridge and focuses on providing location capabilities based on the EPC Class1 Gen2 standard. PervasID's technology employs fixed ultra-high frequency RFID to accurately detect passive tags over long distances, facilitating enhanced visibility into goods, assets, and people. Its innovative systems are designed to serve various industries, including retail, healthcare, supply chain and logistics, and aviation. The technology has been successfully deployed in multiple field trials, demonstrating its reliability and effectiveness in streamlining processes across diverse markets.

PrOXisense

Series A in 2018
Proxisense has developed extreme environment proximity sensors and fluid contamination systems utilising eddy current sensors. The former are finding uses in producing systems which monitor the health of turbine blades in real-time, which can extend component lifetimes and reduce maintenance and downtime costs. Proxisense is targeting the power and aerospace industries for these use cases and is working closely with major OEM players in the fields, including Alstom, Siemens and Rolls-Royce. Contamination of critical fluid systems is a significant issue where transportation assets travel the world and require fuel and lubrication fluids from remote sources. Proxisense’s system can provide real-time, reliable monitoring of these fluids and reduce damage to components, sub-optimal operating conditions and, potentially, system failures.

Dynamic Vision Systems

Venture Round in 2018
Dynamic Vision Systems has develops contact lens for the correction of presbyopia.

Bodle Technologies

Series A in 2018
Bodle Technologies Limited provides advanced optoelectronic solutions for displays and smart windows. It offers zero-power reflective displays that are bi-stable reflective displays with ultra-high resolution; smart windows; and security coatings that change color under mechanical, optical or electrical probing techniques that result in unbreakable security features in currencies, ID cards, and official documentation. Its reflective displays are used in wearables, near-eye, and projection based displays. Bodle Technologies Limited was incorporated in 2015 and is headquartered in Begbroke, United Kingdom.

Inductosense

Series A in 2017
Inductosense Ltd specializes in the manufacture of wireless, battery-free sensors designed for the detection of cracks, corrosion, and defects in various structures and products. Founded in 2015 and based in Bristol, United Kingdom, the company offers innovative solutions such as the WAND Evaluation System, which includes a handheld measurement probe and multiple sensors for measuring structural thickness. Their technology enables sensors to be permanently affixed to surfaces or embedded within materials, allowing for inspections beneath coatings, insulation, or repairs. Additionally, Inductosense provides TRND systems for monitoring internal corrosion and erosion in pipework and vessels. The sensors operate passively, receiving power and transmitting data through non-contact inductive coupling, facilitating fast and repeatable inspections while enabling clients to trend data over time.
Creavo Medical Technologies Ltd. is a UK-based medical device company focused on developing innovative imaging technologies for acute medical settings. Established in 2014, the company was founded by a team of clinical, research, and business experts to commercialize technology created by Professor Ben Varcoe. Creavo offers a portable, battery-powered medical device designed for the detection of heart-related issues, enhancing diagnostic capabilities in urgent care environments. The company operates facilities in Leeds and Coventry, aiming to improve patient outcomes through advanced diagnostic solutions.

Azul Optics

Series B in 2017
Azul Optics is developing a device that can rapidly assess macular pigment density. Their device will be affordable, fast, easy-to-use and compact, making it easy to integrate macular pigment density screening into regular eye exams. Their goal is to introduce a technology that enables eye health professionals to rapidly assess macular pigments as an indicator of eye health.

PrOXisense

Seed Round in 2016
Proxisense has developed extreme environment proximity sensors and fluid contamination systems utilising eddy current sensors. The former are finding uses in producing systems which monitor the health of turbine blades in real-time, which can extend component lifetimes and reduce maintenance and downtime costs. Proxisense is targeting the power and aerospace industries for these use cases and is working closely with major OEM players in the fields, including Alstom, Siemens and Rolls-Royce. Contamination of critical fluid systems is a significant issue where transportation assets travel the world and require fuel and lubrication fluids from remote sources. Proxisense’s system can provide real-time, reliable monitoring of these fluids and reduce damage to components, sub-optimal operating conditions and, potentially, system failures.

PervasID

Series A in 2016
PervasID Limited, founded in 2011 and based in Cambridge, United Kingdom, specializes in the development of wide area passive RFID systems. The company emerged from research conducted at the University of Cambridge and focuses on providing location capabilities based on the EPC Class1 Gen2 standard. PervasID's technology employs fixed ultra-high frequency RFID to accurately detect passive tags over long distances, facilitating enhanced visibility into goods, assets, and people. Its innovative systems are designed to serve various industries, including retail, healthcare, supply chain and logistics, and aviation. The technology has been successfully deployed in multiple field trials, demonstrating its reliability and effectiveness in streamlining processes across diverse markets.

Bodle Technologies

Seed Round in 2015
Bodle Technologies Limited provides advanced optoelectronic solutions for displays and smart windows. It offers zero-power reflective displays that are bi-stable reflective displays with ultra-high resolution; smart windows; and security coatings that change color under mechanical, optical or electrical probing techniques that result in unbreakable security features in currencies, ID cards, and official documentation. Its reflective displays are used in wearables, near-eye, and projection based displays. Bodle Technologies Limited was incorporated in 2015 and is headquartered in Begbroke, United Kingdom.

Cambridge CMOS Sensors

Series C in 2015
Cambridge CMOS Sensors (CCS) is an industry leader in sensor technology and a leading manufacturer of sensor solutions and components for monitoring air quality, including hazardous gases and Volatile Organic Compounds (VOCs). Founded in 2008 as a spin-off from Cambridge University, we are revolutionising environmental sensing for health and well-being through a new generation of semiconductor-based sensors. Our technology offers a radical step change in performance, with significantly lower power consumption, ultra-fast response time, embedded intelligence and ultra-small form factor.

Active Inspiration Technologies

Venture Round in 2015
Award winning digital health platform called "Fuell" with a goal of getting Employees to achieve weekly health goals. Data Collection from wearables Engagement through self service and sponsored challenges Loyalty and Monetisation through tokens Low cost monthly subscription with data driven outcomes for Employers, Brands and Organisations.

Cambridge CMOS Sensors

Series C in 2014
Cambridge CMOS Sensors (CCS) is an industry leader in sensor technology and a leading manufacturer of sensor solutions and components for monitoring air quality, including hazardous gases and Volatile Organic Compounds (VOCs). Founded in 2008 as a spin-off from Cambridge University, we are revolutionising environmental sensing for health and well-being through a new generation of semiconductor-based sensors. Our technology offers a radical step change in performance, with significantly lower power consumption, ultra-fast response time, embedded intelligence and ultra-small form factor.

Cambridge CMOS Sensors

Series B in 2013
Cambridge CMOS Sensors (CCS) is an industry leader in sensor technology and a leading manufacturer of sensor solutions and components for monitoring air quality, including hazardous gases and Volatile Organic Compounds (VOCs). Founded in 2008 as a spin-off from Cambridge University, we are revolutionising environmental sensing for health and well-being through a new generation of semiconductor-based sensors. Our technology offers a radical step change in performance, with significantly lower power consumption, ultra-fast response time, embedded intelligence and ultra-small form factor.

Cambridge CMOS Sensors

Series A in 2012
Cambridge CMOS Sensors (CCS) is an industry leader in sensor technology and a leading manufacturer of sensor solutions and components for monitoring air quality, including hazardous gases and Volatile Organic Compounds (VOCs). Founded in 2008 as a spin-off from Cambridge University, we are revolutionising environmental sensing for health and well-being through a new generation of semiconductor-based sensors. Our technology offers a radical step change in performance, with significantly lower power consumption, ultra-fast response time, embedded intelligence and ultra-small form factor.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.